Ginkgolide B Regulates CDDP Chemoresistance in Oral Cancer via the Platelet-Activating Factor Receptor Pathway

Ginkgolide B Regulates CDDP Chemoresistance in Oral Cancer via the Platelet-Activating Factor Receptor Pathway

The platelet-activating factor receptor (PAFR) is a key molecule that participates in intracellular signaling pathways, including regulating the activation of kinases. It is involved in cancer progression, but the detailed mechanism of its chemosensitivity is unknown. The purpose of the current stud...

Full description

Bibliographic Details
Main Authors: Kohei Kawasaki, Atsushi Kasamatsu, Toshiaki Ando, Tomoaki Saito, Takafumi Nobuchi, Ryunosuke Nozaki, Manabu Iyoda, Katsuhiro Uzawa
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Cancers
Subjects:
platelet-activating factor receptor
cisplatin
ginkgolide B
oral squamous cell carcinoma
combination chemotherapy
Online Access:https://www.mdpi.com/2072-6694/13/24/6299

Internet

https://www.mdpi.com/2072-6694/13/24/6299

Similar Items